We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVEE
1551
DELISTED
NV5 Global
NVEE
| $1.73M | ﹤0.01% |
+70,504
| New | +$1.83M |
|
1552
HealthStream
HSTM
$840M
| $1.73M | ﹤0.01% |
64,779
-1,609
| -2% | -$43K |
|
1553
Taboola.com
TBLA
$1.11B
| $1.73M | ﹤0.01% |
388,926
+238,528
| +159% | +$1.06M |
|
1554
Citi Trends
CTRN
$605M
| $1.72M | ﹤0.01% |
63,487
+18,603
| +41% | +$536K |
|
1555
Preferred Bank
PFBC
$1.25B
| $1.72M | ﹤0.01% |
22,431
-22,478
| -50% | -$1.63M |
|
1556
American Financial Group
AFG
$12.1B
| $1.72M | ﹤0.01% |
12,600
-87,879
| -87% | -$10.9M |
|
1557
ZTO Express
ZTO
$17.9B
| $1.72M | ﹤0.01% |
82,000
-1,384,087
| -94% | -$26.5M |
|
1558
Strategy Inc
MSTR
$38.4B
| $1.71M | ﹤0.01% |
10,050
-746,010
| -99% | -$68M |
|
|
HDSN
1559
Hudson Technologies
HDSN
$235M
| $1.71M | ﹤0.01% |
154,960
-133,787
| -46% | -$1.74M |
|
1560
Infosys
INFY
$50.7B
| $1.71M | ﹤0.01% |
95,100
-948,207
| -91% | -$18.4M |
|
1561
Design Therapeutics
DSGN
$876M
| $1.7M | ﹤0.01% |
422,035
-6,136
| -1% | -$16.4K |
|
1562
Patterson-UTI
PTEN
$3.76B
| $1.7M | ﹤0.01% |
142,290
-779,906
| -85% | -$8.66M |
|
|
YMAB
1563
DELISTED
Y-mAbs Therapeutics
YMAB
| $1.7M | ﹤0.01% |
104,302
+42,463
| +69% | +$572K |
|
1564
Columbus McKinnon
CMCO
$584M
| $1.69M | ﹤0.01% |
37,912
-47,421
| -56% | -$1.92M |
|
1565
Wintrust Financial
WTFC
$10.7B
| $1.69M | ﹤0.01% |
16,200
-1,200
| -7% | -$116K |
|
|
MITT
1566
TPG Mortgage Investment Trust
MITT
$225M
| $1.69M | ﹤0.01% |
275,767
+47,699
| +21% | +$293K |
|
1567
Deere & Co
DE
$168B
| $1.68M | ﹤0.01% |
4,100
-30,211
| -88% | -$11.6M |
|
1568
Ocugen
OCGN
$434M
| $1.68M | ﹤0.01% |
1,026,008
+868,704
| +552% | +$728K |
|
1569
Esquire Financial Holdings
ESQ
$1.14B
| $1.67M | ﹤0.01% |
35,279
+13,454
| +62% | +$659K |
|
|
VGR
1570
DELISTED
Vector Group Ltd.
VGR
| $1.67M | ﹤0.01% |
152,078
-43,921
| -22% | -$477K |
|
|
DVAX
1571
DELISTED
Dynavax Technologies
DVAX
| $1.66M | ﹤0.01% |
133,809
-9,573
| -7% | -$125K |
|
1572
Quaker Houghton
KWR
$2.92B
| $1.65M | ﹤0.01% |
8,063
+1,523
| +23% | +$302K |
|
1573
White Mountains Insurance
WTM
$5.13B
| $1.65M | ﹤0.01% |
922
+500
| +118% | +$838K |
|
1574
Fulcrum Therapeutics
FULC
$297M
| $1.65M | ﹤0.01% |
175,224
-86,528
| -33% | -$772K |
|
1575
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.4B
| $1.65M | ﹤0.01% |
+38,382
| New | +$1.59M |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.